Summary of Changes - 1 July 2026

The PBS Schedule is updated on the first day of every month and can also be viewed in other formats found on the PBS Publications & Downloads page.

Previous versions of the Summary of Changes are also available in PDF in the Publications Archive.

Prescriber Bag

Additions

Addition – Item

15406W BENZATHINE BENZYLPENICILLIN, benzathine benzylpenicillin 1.2 million units powder for injection, 1 vial (Benzylpenicillin benzathine (Brancaster Pharma, UK))

Alterations

Alteration – Note

15053G BENZATHINE BENZYLPENICILLIN, benzathine benzylpenicillin 1.2 million units powder for injection [1 vial] (&) inert substance diluent [4 mL ampoule], 1 pack (Lentocilin S 1200 (Portugal))
11755Q BENZATHINE BENZYLPENICILLIN, benzathine benzylpenicillin tetrahydrate 1.2 million units (1016.6 mg)/2.3 mL injection, 10 x 2.3 mL syringes (Bicillin L-A)

General Pharmaceutical Benefits

Additions

Addition – Item

15414G ADRENALINE (EPINEPHRINE), Adrenaline (epinephrine) 1 mg/actuation nasal spray, 2 x 1 actuation (neffy)
15404R ADRENALINE (EPINEPHRINE), Adrenaline (epinephrine) 2 mg/actuation nasal spray, 2 x 1 actuation (neffy)
15376G ALECTINIB, alectinib 150 mg capsule, 4 x 56 (Alecensa)
15365Q BENZATHINE BENZYLPENICILLIN, benzathine benzylpenicillin 1.2 million units powder for injection, 1 vial (Benzylpenicillin benzathine (Brancaster Pharma, UK))
15389Y BENZATHINE BENZYLPENICILLIN, benzathine benzylpenicillin 1.2 million units powder for injection, 1 vial (Benzylpenicillin benzathine (Brancaster Pharma, UK))
15401N FUTIBATINIB, Futibatinib 4 mg tablet, 35 (Lytgobi)
15393E INSULIN DEGLUDEC, insulin degludec 100 units/mL injection, 5 x 3 mL cartridges (Tresiba Penfill)
15377H METHADONE, methadone hydrochloride 5 mg tablet, 20 (METHADONE-AFT)
15381M MIDAZOLAM, midazolam 2.5 mg/0.25 mL oral liquid, 0.25 mL syringe (Zyamis)
15388X MIDAZOLAM, midazolam 2.5 mg/0.25 mL oral liquid, 0.25 mL syringe (Zyamis)
15378J OSIMERTINIB, osimertinib 40 mg tablet, 30 (Tagrisso)
15392D OSIMERTINIB, osimertinib 80 mg tablet, 30 (Tagrisso)
15415H PHENOBARBITAL, phenobarbital 30 mg tablet, 100 (Phenobarbital Tablets, USP 30 mg (Rising Pharmaceuticals, USA))
15371B SELPERCATINIB, Selpercatinib 40 mg tablet, 56 (Retevmo)
15416J SELPERCATINIB, Selpercatinib 80 mg tablet, 56 (Retevmo)
15366R TENOFOVIR DISOPROXIL + EMTRICITABINE, tenofovir disoproxil maleate 300 mg + emtricitabine 200 mg tablet, 30 (Tenofovir Disoproxil Emtricitabine Viatris 300/200)
15383P TENOFOVIR DISOPROXIL + EMTRICITABINE, tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg tablet, 30 (CIPLA TENOFOVIR + EMTRICITABINE 300/200, TENOFOVIR/EMTRICITABINE 300/200 APX, TENOFOVIR/EMTRICITABINE 300/200 ARX)
15410C TENOFOVIR DISOPROXIL + EMTRICITABINE, tenofovir disoproxil succinate 301 mg + emtricitabine 200 mg tablet, 30 (Tenofovir/Emtricitabine Sandoz 301/200)
15380L TRIGLYCERIDES MEDIUM CHAIN FORMULA, triglycerides medium chain formula powder for oral liquid, 400 g (Monogen)
15382N UPADACITINIB, upadacitinib 30 mg modified release tablet, 28 (Rinvoq)
15368W USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Wezlana)
15390B USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Wezlana)
15397J USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Wezlana)
15400M USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Wezlana)

Addition – Brand

5468T Dutacor, CR – DUTASTERIDE, dutasteride 500 microgram capsule, 30
13900N Dutacor, CR – DUTASTERIDE, dutasteride 500 microgram capsule, 30
1598D ARX-Mercaptopurine, XT – MERCAPTOPURINE, mercaptopurine monohydrate 50 mg tablet, 25
9449H Blooms The Chemist Sitagliptin/Metformin 50/500, BG – SITAGLIPTIN + METFORMIN, sitagliptin 50 mg + metformin hydrochloride 500 mg tablet, 56
13994M Blooms The Chemist Sitagliptin/Metformin 50/500, BG – SITAGLIPTIN + METFORMIN, sitagliptin 50 mg + metformin hydrochloride 500 mg tablet, 56
9450J Blooms The Chemist Sitagliptin/Metformin 50/850, BG – SITAGLIPTIN + METFORMIN, sitagliptin 50 mg + metformin hydrochloride 850 mg tablet, 56
14064F Blooms The Chemist Sitagliptin/Metformin 50/850, BG – SITAGLIPTIN + METFORMIN, sitagliptin 50 mg + metformin hydrochloride 850 mg tablet, 56
10090C Sitagliptin/Metformin XR KND, CR – SITAGLIPTIN + METFORMIN, sitagliptin 50 mg + metformin hydrochloride 1 g modified release tablet, 56
13990H Sitagliptin/Metformin XR KND, CR – SITAGLIPTIN + METFORMIN, sitagliptin 50 mg + metformin hydrochloride 1 g modified release tablet, 56
9451K Blooms The Chemist Sitagliptin/Metformin 50/1000, BG – SITAGLIPTIN + METFORMIN, sitagliptin 50 mg + metformin hydrochloride 1 g tablet, 56
14035Q Blooms The Chemist Sitagliptin/Metformin 50/1000, BG – SITAGLIPTIN + METFORMIN, sitagliptin 50 mg + metformin hydrochloride 1 g tablet, 56
10089B Sitagliptin/Metformin XR KND, CR – SITAGLIPTIN + METFORMIN, sitagliptin 100 mg + metformin hydrochloride 1 g modified release tablet, 28
14031L Sitagliptin/Metformin XR KND, CR – SITAGLIPTIN + METFORMIN, sitagliptin 100 mg + metformin hydrochloride 1 g modified release tablet, 28
1418P Ticagrelor SUN, RA – TICAGRELOR, ticagrelor 90 mg tablet, 56
13524T Ticagrelor SUN, RA – TICAGRELOR, ticagrelor 90 mg tablet, 56
14877B Wezlana, AN – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe
14879D Wezlana, AN – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe
14890Q Wezlana, AN – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe
14891R Wezlana, AN – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe
14892T Wezlana, AN – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe
14898D Wezlana, AN – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe
14899E Wezlana, AN – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe
14908P Wezlana, AN – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe
14909Q Wezlana, AN – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe
14916C Wezlana, AN – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe
14933Y Wezlana, AN – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe
14944M Wezlana, AN – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe
9304Q Wezlana, AN – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial
9305R Wezlana, AN – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial
10767Q Wezlana, AN – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial
10774C Wezlana, AN – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial
11178H Wezlana, AN – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial
12662K Wezlana, AN – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial
12664M Wezlana, AN – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial
12669T Wezlana, AN – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial
13261Y Wezlana, AN – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe
13273N Wezlana, AN – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe
13789R Wezlana, AN – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe
13805N Wezlana, AN – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe
14878C Wezlana, AN – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe
14893W Wezlana, AN – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe
14897C Wezlana, AN – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe
14907N Wezlana, AN – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe
14917D Wezlana, AN – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe
14918E Wezlana, AN – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe
14926N Wezlana, AN – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe
14934B Wezlana, AN – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe
14935C Wezlana, AN – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe
14943L Wezlana, AN – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe

Addition – Equivalence Indicator

1850J Phenobarb, RW – PHENOBARBITAL, phenobarbital 30 mg tablet, 200
14693H Retevmo, LY – SELPERCATINIB, Selpercatinib 40 mg capsule, 56
14703W Retevmo, LY – SELPERCATINIB, selpercatinib 80 mg capsule, 56
14877B Steqeyma, EW – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe
14879D Steqeyma, EW – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe
14890Q Steqeyma, EW – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe
14891R Steqeyma, EW – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe
14892T Steqeyma, EW – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe
14898D Steqeyma, EW – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe
14899E Steqeyma, EW – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe
14908P Steqeyma, EW – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe
14909Q Steqeyma, EW – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe
14916C Steqeyma, EW – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe
14933Y Steqeyma, EW – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe
14944M Steqeyma, EW – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe
9304Q Stelara, JC – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial
9305R Stelara, JC – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial
10767Q Stelara, JC – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial
10774C Stelara, JC – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial
11178H Stelara, JC – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial
12662K Stelara, JC – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial
12664M Stelara, JC – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial
12669T Stelara, JC – USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial
14878C Steqeyma, EW – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe
14893W Steqeyma, EW – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe
14897C Steqeyma, EW – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe
14907N Steqeyma, EW – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe
14917D Steqeyma, EW – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe
14918E Steqeyma, EW – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe
14926N Steqeyma, EW – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe
14934B Steqeyma, EW – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe
14935C Steqeyma, EW – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe
14943L Steqeyma, EW – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe

Addition – Note

1850J PHENOBARBITAL, phenobarbital 30 mg tablet, 200 (Phenobarb)
14693H SELPERCATINIB, selpercatinib 40 mg capsule, 56 (Retevmo) - Supply Only
14703W SELPERCATINIB, selpercatinib 80 mg capsule, 56 (Retevmo) - Supply Only

Addition – Caution

8697R ADRENALINE (EPINEPHRINE), adrenaline (epinephrine) 150 microgram/0.3 mL injection, 0.3 mL pen device (Adrenaline Jr Viatris, Anapen Junior 150, EpiPen Jr.)
8698T ADRENALINE (EPINEPHRINE), adrenaline (epinephrine) 300 microgram/0.3 mL injection, 0.3 mL pen device (Adrenaline Viatris, Anapen 300, EpiPen)
12655C ADRENALINE (EPINEPHRINE), adrenaline (epinephrine) 500 microgram/0.3 mL injection, 0.3 mL pen device (Anapen 500)

Deletions

Deletion – Brand

5551E Bimtop, AF – BIMATOPROST, bimatoprost 0.03% eye drops, 3 mL
8620Q Bimtop, AF – BIMATOPROST, bimatoprost 0.03% eye drops, 3 mL
14315K Bimtop, AF – BIMATOPROST, bimatoprost 0.03% eye drops, 3 mL
8362D Capecitabine Sandoz, SZ – CAPECITABINE, capecitabine 500 mg tablet, 120
9483D EzSimva GH 10/10, GQ – EZETIMIBE + SIMVASTATIN, ezetimibe 10 mg + simvastatin 10 mg tablet, 30
13385L EzSimva GH 10/10, GQ – EZETIMIBE + SIMVASTATIN, ezetimibe 10 mg + simvastatin 10 mg tablet, 30
8887R Meloxicam Sandoz, SZ – MELOXICAM, meloxicam 7.5 mg capsule, 30
8888T Meloxicam Sandoz, SZ – MELOXICAM, meloxicam 15 mg capsule, 30
3050M Idaprex 2, SZ – PERINDOPRIL, perindopril erbumine 2 mg tablet, 30
13404L Idaprex 2, SZ – PERINDOPRIL, perindopril erbumine 2 mg tablet, 30
3051N Idaprex 4, SZ – PERINDOPRIL, perindopril erbumine 4 mg tablet, 30
13371R Idaprex 4, SZ – PERINDOPRIL, perindopril erbumine 4 mg tablet, 30
8704D Idaprex 8, SZ – PERINDOPRIL, perindopril erbumine 8 mg tablet, 30
13372T Idaprex 8, SZ – PERINDOPRIL, perindopril erbumine 8 mg tablet, 30
8449Q Idaprex Combi 4/1.25, SZ – PERINDOPRIL + INDAPAMIDE, perindopril erbumine 4 mg + indapamide hemihydrate 1.25 mg tablet, 30
13476G Idaprex Combi 4/1.25, SZ – PERINDOPRIL + INDAPAMIDE, perindopril erbumine 4 mg + indapamide hemihydrate 1.25 mg tablet, 30
1952R Rasagiline Sandoz, SZ – RASAGILINE, rasagiline 1 mg tablet, 30
14458Y Rasagiline Sandoz, SZ – RASAGILINE, rasagiline 1 mg tablet, 30

Deletion – Equivalence Indicator

8362D Xelabine, AL – CAPECITABINE, capecitabine 500 mg tablet, 120
11366F LINCOMYCIN SXP, XN – LINCOMYCIN, lincomycin 600 mg/2 mL injection, 5 x 2 mL ampoules
11380Y LINCOMYCIN SXP, XN – LINCOMYCIN, lincomycin 600 mg/2 mL injection, 5 x 2 mL ampoules

Deletion – Note

11366F LINCOMYCIN, lincomycin 600 mg/2 mL injection, 5 x 2 mL ampoules (LINCOMYCIN SXP)
11380Y LINCOMYCIN, lincomycin 600 mg/2 mL injection, 5 x 2 mL ampoules (LINCOMYCIN SXP)
9327X MEDIUM CHAIN TRIGLYCERIDES, medium chain triglycerides oral liquid, 250 mL bottle (Liquigen)
3128P MEDIUM CHAIN TRIGLYCERIDES, medium chain triglycerides oral oil, 500 mL (MCT Oil)
12948L TRIGLYCERIDES MEDIUM CHAIN FORMULA, triglycerides medium chain formula oral liquid, 12 x 500 mL bottles (Nutrini Peptisorb)
1938B TRIGLYCERIDES MEDIUM CHAIN FORMULA, triglycerides medium chain formula powder for oral liquid, 400 g (Lipistart)
10154K TRIGLYCERIDES MEDIUM CHAIN FORMULA, triglycerides medium chain formula powder for oral liquid, 400 g (Peptamen Junior)
10155L TRIGLYCERIDES MEDIUM CHAIN FORMULA, triglycerides medium chain formula powder for oral liquid, 400 g (Lipistart)

Deletion – Caution

8697R ADRENALINE (EPINEPHRINE), adrenaline (epinephrine) 150 microgram/0.3 mL injection, 0.3 mL pen device (Adrenaline Jr Viatris, Anapen Junior 150, EpiPen Jr.)
8698T ADRENALINE (EPINEPHRINE), adrenaline (epinephrine) 300 microgram/0.3 mL injection, 0.3 mL pen device (Adrenaline Viatris, Anapen 300, EpiPen)
12655C ADRENALINE (EPINEPHRINE), adrenaline (epinephrine) 500 microgram/0.3 mL injection, 0.3 mL pen device (Anapen 500)

Alterations

Alteration – Note

12345R ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices (Hadlima, Humira, Hyrimoz, Yuflyma)
12389C ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices (Hadlima, Humira, Hyrimoz, Yuflyma)
12410E ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes (Hadlima, Humira, Hyrimoz, Yuflyma)
12433J ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices (Hadlima, Humira, Hyrimoz, Yuflyma)
12451H ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes (Hadlima, Humira, Hyrimoz, Yuflyma)
12453K ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes (Hadlima, Humira, Hyrimoz, Yuflyma)
13219R ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes (Hadlima, Hyrimoz, Yuflyma)
13225C ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices (Hadlima, Hyrimoz, Yuflyma)
9188N ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (Amgevita, Hadlima, Hyrimoz)
9189P ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (Amgevita, Hadlima, Hyrimoz)
9190Q ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (Abrilada, Amgevita, Hadlima, Hyrimoz)
9191R ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (Abrilada, Amgevita, Hadlima, Hyrimoz)
12352D ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (Abrilada, Amgevita, Hadlima, Hyrimoz)
12387Y ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (Amgevita, Hadlima, Hyrimoz)
12402R ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (Abrilada, Amgevita, Hadlima, Hyrimoz)
12437N ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (Amgevita, Hadlima, Hyrimoz)
12372E ADALIMUMAB, adalimumab 80 mg/0.8 mL injection, 0.8 mL syringe (Humira, Yuflyma)
12419P ADALIMUMAB, adalimumab 80 mg/0.8 mL injection, 0.8 mL pen device (Humira, Hyrimoz, Yuflyma)
8697R ADRENALINE (EPINEPHRINE), adrenaline (epinephrine) 150 microgram/0.3 mL injection, 0.3 mL pen device (Adrenaline Jr Viatris, Anapen Junior 150, EpiPen Jr.)
8698T ADRENALINE (EPINEPHRINE), adrenaline (epinephrine) 300 microgram/0.3 mL injection, 0.3 mL pen device (Adrenaline Viatris, Anapen 300, EpiPen)
12655C ADRENALINE (EPINEPHRINE), adrenaline (epinephrine) 500 microgram/0.3 mL injection, 0.3 mL pen device (Anapen 500)
15058M BENZATHINE BENZYLPENICILLIN, benzathine benzylpenicillin 1.2 million units powder for injection [1 vial] (&) inert substance diluent [4 mL ampoule], 1 pack (Lentocilin S 1200 (Portugal))
15063T BENZATHINE BENZYLPENICILLIN, benzathine benzylpenicillin 1.2 million units powder for injection [1 vial] (&) inert substance diluent [4 mL ampoule], 1 pack (Lentocilin S 1200 (Portugal))
2267H BENZATHINE BENZYLPENICILLIN, benzathine benzylpenicillin tetrahydrate 1.2 million units (1016.6 mg)/2.3 mL injection, 10 x 2.3 mL syringes (Bicillin L-A)
5027N BENZATHINE BENZYLPENICILLIN, benzathine benzylpenicillin tetrahydrate 1.2 million units (1016.6 mg)/2.3 mL injection, 10 x 2.3 mL syringes (Bicillin L-A)
12551N INFLIXIMAB, infliximab 120 mg/mL injection, 1 mL pen device (Remsima SC)
12560C INFLIXIMAB, infliximab 120 mg/mL injection, 1 mL pen device (Remsima SC)
12567K INFLIXIMAB, infliximab 120 mg/mL injection, 1 mL pen device (Remsima SC)
12585J INFLIXIMAB, infliximab 120 mg/mL injection, 1 mL syringe (Remsima SC)
12586K INFLIXIMAB, infliximab 120 mg/mL injection, 1 mL syringe (Remsima SC)
12597B INFLIXIMAB, infliximab 120 mg/mL injection, 1 mL syringe (Remsima SC)
13768P UPADACITINIB, upadacitinib 15 mg modified release tablet, 28 (Rinvoq)
13746L UPADACITINIB, upadacitinib 30 mg modified release tablet, 28 (Rinvoq)
13762H UPADACITINIB, upadacitinib 30 mg modified release tablet, 28 (Rinvoq)
13771T UPADACITINIB, upadacitinib 45 mg modified release tablet, 28 (Rinvoq)
11178H USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Stelara, Wezlana)
14898D USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe (Steqeyma, Wezlana)
14909Q USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe (Steqeyma, Wezlana)
14926N USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Steqeyma, Wezlana)
14934B USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Steqeyma, Wezlana)
12620F VEDOLIZUMAB, vedolizumab 108 mg/0.68 mL injection, 2 x 0.68 mL pen devices (Entyvio)
12638E VEDOLIZUMAB, vedolizumab 108 mg/0.68 mL injection, 2 x 0.68 mL pen devices (Entyvio)
12654B VEDOLIZUMAB, vedolizumab 108 mg/0.68 mL injection, 2 x 0.68 mL pen devices (Entyvio)

Alteration – Restriction

12345R ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices (Hadlima, Humira, Hyrimoz, Yuflyma)
12389C ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices (Hadlima, Humira, Hyrimoz, Yuflyma)
12410E ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes (Hadlima, Humira, Hyrimoz, Yuflyma)
12433J ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices (Hadlima, Humira, Hyrimoz, Yuflyma)
12451H ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes (Hadlima, Humira, Hyrimoz, Yuflyma)
12453K ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes (Hadlima, Humira, Hyrimoz, Yuflyma)
13219R ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes (Hadlima, Hyrimoz, Yuflyma)
13225C ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices (Hadlima, Hyrimoz, Yuflyma)
9188N ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (Amgevita, Hadlima, Hyrimoz)
9189P ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (Amgevita, Hadlima, Hyrimoz)
9190Q ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (Abrilada, Amgevita, Hadlima, Hyrimoz)
9191R ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (Abrilada, Amgevita, Hadlima, Hyrimoz)
12352D ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (Abrilada, Amgevita, Hadlima, Hyrimoz)
12387Y ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (Amgevita, Hadlima, Hyrimoz)
12402R ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (Abrilada, Amgevita, Hadlima, Hyrimoz)
12437N ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (Amgevita, Hadlima, Hyrimoz)
12372E ADALIMUMAB, adalimumab 80 mg/0.8 mL injection, 0.8 mL syringe (Humira, Yuflyma)
12419P ADALIMUMAB, adalimumab 80 mg/0.8 mL injection, 0.8 mL pen device (Humira, Hyrimoz, Yuflyma)
15359J ADRENALINE (EPINEPHRINE), adrenaline (epinephrine) 150 microgram/0.15 mL injection, 0.15 mL pen device (Jext Jnr)
8697R ADRENALINE (EPINEPHRINE), adrenaline (epinephrine) 150 microgram/0.3 mL injection, 0.3 mL pen device (Adrenaline Jr Viatris, Anapen Junior 150, EpiPen Jr.)
8698T ADRENALINE (EPINEPHRINE), adrenaline (epinephrine) 300 microgram/0.3 mL injection, 0.3 mL pen device (Adrenaline Viatris, Anapen 300, EpiPen)
15355E ADRENALINE (EPINEPHRINE), adrenaline (epinephrine) 300 microgram/0.3 mL injection, 0.3 mL pen device (Jext)
12655C ADRENALINE (EPINEPHRINE), adrenaline (epinephrine) 500 microgram/0.3 mL injection, 0.3 mL pen device (Anapen 500)
11226W ALECTINIB, alectinib 150 mg capsule, 4 x 56 (Alecensa)
15337F GLYCOPYRRONIUM, Glycopyrronium 2.2 mg/actuation cream, 124 actuations (Axhidrox)
12551N INFLIXIMAB, infliximab 120 mg/mL injection, 1 mL pen device (Remsima SC)
12560C INFLIXIMAB, infliximab 120 mg/mL injection, 1 mL pen device (Remsima SC)
12567K INFLIXIMAB, infliximab 120 mg/mL injection, 1 mL pen device (Remsima SC)
12585J INFLIXIMAB, infliximab 120 mg/mL injection, 1 mL syringe (Remsima SC)
12586K INFLIXIMAB, infliximab 120 mg/mL injection, 1 mL syringe (Remsima SC)
12597B INFLIXIMAB, infliximab 120 mg/mL injection, 1 mL syringe (Remsima SC)
14292F MIDAZOLAM, midazolam 5 mg/0.5 mL oral liquid, 0.5 mL syringe (Zyamis)
14238J MIDAZOLAM, midazolam 7.5 mg/0.75 mL oral liquid, 0.75 mL syringe (Zyamis)
14270C MIDAZOLAM, midazolam 10 mg/mL oral liquid, 1 mL syringe (Zyamis)
10154K TRIGLYCERIDES MEDIUM CHAIN FORMULA, triglycerides medium chain formula powder for oral liquid, 400 g (Peptamen Junior)
13768P UPADACITINIB, upadacitinib 15 mg modified release tablet, 28 (Rinvoq)
13746L UPADACITINIB, upadacitinib 30 mg modified release tablet, 28 (Rinvoq)
13762H UPADACITINIB, upadacitinib 30 mg modified release tablet, 28 (Rinvoq)
13771T UPADACITINIB, upadacitinib 45 mg modified release tablet, 28 (Rinvoq)
11178H USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Stelara, Wezlana)
12664M USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Stelara, Wezlana)
14891R USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe (Steqeyma, Wezlana)
14898D USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe (Steqeyma, Wezlana)
14909Q USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe (Steqeyma, Wezlana)
14926N USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Steqeyma, Wezlana)
14934B USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Steqeyma, Wezlana)
14943L USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Steqeyma, Wezlana)
12620F VEDOLIZUMAB, vedolizumab 108 mg/0.68 mL injection, 2 x 0.68 mL pen devices (Entyvio)
12638E VEDOLIZUMAB, vedolizumab 108 mg/0.68 mL injection, 2 x 0.68 mL pen devices (Entyvio)
12654B VEDOLIZUMAB, vedolizumab 108 mg/0.68 mL injection, 2 x 0.68 mL pen devices (Entyvio)

Alteration – Manufacturer Code

From To
10922W Nuvigil – ARMODAFINIL, armodafinil 50 mg tablet, 30 TB FW
10912H Nuvigil – ARMODAFINIL, armodafinil 150 mg tablet, 30 TB FW
10919Q Nuvigil – ARMODAFINIL, armodafinil 250 mg tablet, 30 TB FW
5457F CORORA – DENOSUMAB, denosumab 60 mg/mL injection, 1 mL syringe GV XW
5457F Prolia – DENOSUMAB, denosumab 60 mg/mL injection, 1 mL syringe AN XT
15001M Xgeva – DENOSUMAB, denosumab 120 mg/mL injection, 1 mL syringe AN XT
15013E Xgeva – DENOSUMAB, denosumab 120 mg/mL injection, 1 mL syringe AN XT
5110Y GANVADO – DENOSUMAB, denosumab 120 mg/1.7 mL injection, 1.7 mL vial GV XW
10061M GANVADO – DENOSUMAB, denosumab 120 mg/1.7 mL injection, 1.7 mL vial GV XW
5110Y Xgeva – DENOSUMAB, denosumab 120 mg/1.7 mL injection, 1.7 mL vial AN XT
10061M Xgeva – DENOSUMAB, denosumab 120 mg/1.7 mL injection, 1.7 mL vial AN XT
8816B Modavigil – MODAFINIL, modafinil 100 mg tablet, 60 TB FW

Supply Only

Supply Only – Period Commencing

11620N OSIMERTINIB, osimertinib 40 mg tablet, 30 (Tagrisso)
12233W OSIMERTINIB, osimertinib 40 mg tablet, 30 (Tagrisso)
14162J OSIMERTINIB, osimertinib 40 mg tablet, 30 (Tagrisso)
11622Q OSIMERTINIB, osimertinib 80 mg tablet, 30 (Tagrisso)
12232T OSIMERTINIB, osimertinib 80 mg tablet, 30 (Tagrisso)
14168Q OSIMERTINIB, osimertinib 80 mg tablet, 30 (Tagrisso)
14693H SELPERCATINIB, Selpercatinib 40 mg capsule, 56 (Retevmo)
14703W SELPERCATINIB, selpercatinib 80 mg capsule, 56 (Retevmo)
8478F TRIGLYCERIDES MEDIUM CHAIN FORMULA, triglycerides medium chain formula powder for oral liquid, 400 g (Monogen)
10152H TRIGLYCERIDES MEDIUM CHAIN FORMULA, triglycerides medium chain formula powder for oral liquid, 400 g (Monogen)

Supply Only – Period Ending

11245W GLYCOMACROPEPTIDE FORMULA WITH DOCOSAHEXAENOIC ACID AND LOW PHENYLALANINE, glycomacropeptide formula with docosahexaenoic acid and low phenylalanine powder for oral liquid, 30 x 27 g sachets (PKU Sphere15)
2530E LINCOMYCIN, lincomycin 600 mg/2 mL injection, 5 x 2 mL vials (Lincocin)
5144R LINCOMYCIN, lincomycin 600 mg/2 mL injection, 5 x 2 mL vials (Lincocin)
2481N OXYCODONE, oxycodone 30 mg suppository, 12 (Proladone)
5194J OXYCODONE, oxycodone 30 mg suppository, 12 (Proladone)
11286B SAXAGLIPTIN + DAPAGLIFLOZIN, saxagliptin 5 mg + dapagliflozin 10 mg tablet, 28 (Qtern 5/10)
13855F SAXAGLIPTIN + DAPAGLIFLOZIN, saxagliptin 5 mg + dapagliflozin 10 mg tablet, 28 (Qtern 5/10)

Advance Notices

1 August 2026

Deletion – Item
8409N Qvar 100 Autohaler, IL – BECLOMETASONE, beclometasone dipropionate 100 microgram/actuation breath activated inhalation, 200 actuations
14514X Qvar 100 Autohaler, IL – BECLOMETASONE, beclometasone dipropionate 100 microgram/actuation breath activated inhalation, 200 actuations
15076L Clopidogrel Tablets, USP 75 mg (Novadoz, USA), KQ – CLOPIDOGREL, clopidogrel 75 mg tablet, 30
15081R Clopidogrel Tablets, USP 75 mg (Aurobindo, USA), LM – CLOPIDOGREL, clopidogrel 75 mg tablet, 30
15085Y Clopidogrel Tablets, USP 75 mg (Aurobindo, USA), LM – CLOPIDOGREL, clopidogrel 75 mg tablet, 30
15086B Clopidogrel Tablets, USP 75 mg (Novadoz, USA), KQ – CLOPIDOGREL, clopidogrel 75 mg tablet, 30
1610R Leucovorin Calcium (Pfizer Australia Pty Ltd), PF – FOLINIC ACID, folinic acid 50 mg/5 mL injection, 10 x 5 mL ampoules
8027L Minitran 5, IL – GLYCERYL TRINITRATE, glyceryl trinitrate 5 mg/24 hours patch, 30
14371J Minitran 5, IL – GLYCERYL TRINITRATE, glyceryl trinitrate 5 mg/24 hours patch, 30
8084L Humalog, LY – INSULIN LISPRO, insulin lispro 100 units/mL injection, 1 x 10 mL vial
1426C Humulin 30/70, LY – INSULIN NEUTRAL HUMAN + INSULIN ISOPHANE HUMAN, insulin neutral human 30 units/mL + insulin isophane human 70 units/mL injection, 10 mL vial
15109F Ritalin LA 10 mg (Switzerland), KQ – METHYLPHENIDATE, methylphenidate hydrochloride 10 mg modified release capsule, 30
15101T Ritalin LA 20 mg (Switzerland), KQ – METHYLPHENIDATE, methylphenidate hydrochloride 20 mg modified release capsule, 30
15070E Ritalin LA 30 mg (Switzerland), KQ – METHYLPHENIDATE, methylphenidate hydrochloride 30 mg modified release capsule, 100
15099Q Ritalin LA 30 mg (Switzerland), KQ – METHYLPHENIDATE, methylphenidate hydrochloride 30 mg modified release capsule, 30
15100R Ritalin LA 40 mg (Switzerland), KQ – METHYLPHENIDATE, methylphenidate hydrochloride 40 mg modified release capsule, 30
9031H Daktarin Tincture, JT – MICONAZOLE, miconazole 2% solution, 30 mL
Deletion – Brand
3094W Keflex, AS – CEFALEXIN, cefalexin 125 mg/5 mL powder for oral liquid, 100 mL
3319Q Keflex, AS – CEFALEXIN, cefalexin 125 mg/5 mL powder for oral liquid, 100 mL
1533Q Humulin NPH, LY – INSULIN ISOPHANE HUMAN, insulin isophane human 100 units/mL injection, 1 x 10 mL vial
1531N Humulin R, LY – INSULIN NEUTRAL HUMAN, insulin neutral human 100 units/mL injection, 1 x 10 mL vial
1928L Depo-Nisolone, FZ – METHYLPREDNISOLONE, methylprednisolone acetate 40 mg/mL modified release injection, 5 x 1 mL vials
5148Y Depo-Nisolone, FZ – METHYLPREDNISOLONE, methylprednisolone acetate 40 mg/mL modified release injection, 5 x 1 mL vials
3382B OLANZAPINE ODT-WGR, WG – OLANZAPINE, olanzapine 10 mg orally disintegrating tablet, 28
1944H Ramipril Winthrop, WA – RAMIPRIL, ramipril 1.25 mg tablet, 30
13582W Ramipril Winthrop, WA – RAMIPRIL, ramipril 1.25 mg tablet, 30
8380C Temodal, MK – TEMOZOLOMIDE, temozolomide 100 mg capsule, 5
8821G Temodal, MK – TEMOZOLOMIDE, temozolomide 100 mg capsule, 5
9361Q Temodal, MK – TEMOZOLOMIDE, temozolomide 140 mg capsule, 5
9362R Temodal, MK – TEMOZOLOMIDE, temozolomide 140 mg capsule, 5

1 September 2026

Deletion – Item
1750D Poly Visc, IQ – PARAFFIN, paraffin 1 g/g eye ointment, 2 x 3.5 g
5522P Poly Visc, IQ – PARAFFIN, paraffin 1 g/g eye ointment, 2 x 3.5 g
14493T Poly Visc, IQ – PARAFFIN, paraffin 1 g/g eye ointment, 2 x 3.5 g
Deletion – Brand
1884E Amoxil, AS – AMOXICILLIN, amoxicillin 250 mg capsule, 20
3301R Amoxil, AS – AMOXICILLIN, amoxicillin 250 mg capsule, 20
11998L Amoxil, AS – AMOXICILLIN, amoxicillin 250 mg capsule, 20
8533D GLIMEPIRIDE-WGR, WG – GLIMEPIRIDE, glimepiride 3 mg tablet, 30
14020X GLIMEPIRIDE-WGR, WG – GLIMEPIRIDE, glimepiride 3 mg tablet, 30
3385E OLANZAPINE ODT-WGR, WG – OLANZAPINE, olanzapine 20 mg orally disintegrating tablet, 28
8695P Actos, GQ – PIOGLITAZONE, pioglitazone 30 mg tablet, 28
13921Q Actos, GQ – PIOGLITAZONE, pioglitazone 30 mg tablet, 28

1 October 2026

Deletion – Brand
2604C NOUMED ALLOPURINOL, VO – ALLOPURINOL, allopurinol 300 mg tablet, 60
13575L NOUMED ALLOPURINOL, VO – ALLOPURINOL, allopurinol 300 mg tablet, 60
8655M Levetiracetam Mylan, AL – LEVETIRACETAM, levetiracetam 500 mg tablet, 60
14034P Levetiracetam Mylan, AL – LEVETIRACETAM, levetiracetam 500 mg tablet, 60

Palliative Care

Additions

Addition – Item

15412E METHADONE, methadone hydrochloride 5 mg tablet, 20 (METHADONE-AFT)

Highly Specialised Drugs Program (Private Hospital)

Additions

Addition – Item

15362M ROZANOLIXIZUMAB, Rozanolixizumab 280 mg/2 mL injection, 2 mL vial (Rystiggo)
15375F ROZANOLIXIZUMAB, Rozanolixizumab 280 mg/2 mL injection, 2 mL vial (Rystiggo)
15363N TEZEPELUMAB, Tezepelumab 210 mg/1.91 mL injection, 1.91 mL pen device (Tezspire)
15364P TEZEPELUMAB, Tezepelumab 210 mg/1.91 mL injection, 1.91 mL pen device (Tezspire)

Addition – Brand

11164N Wezlana, AN – USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial
13255P Wezlana, AN – USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial
13804M Wezlana, AN – USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial

Deletions

Deletion – Item

6480C EPOETIN BETA, epoetin beta 2000 units/0.3 mL injection, 6 x 0.3 mL syringes (NeoRecormon)
6481D EPOETIN BETA, epoetin beta 3000 units/0.3 mL injection, 6 x 0.3 mL syringes (NeoRecormon)
6482E EPOETIN BETA, epoetin beta 4000 units/0.3 mL injection, 6 x 0.3 mL syringes (NeoRecormon)
6483F EPOETIN BETA, epoetin beta 5000 units/0.3 mL injection, 6 x 0.3 mL syringes (NeoRecormon)
6484G EPOETIN BETA, epoetin beta 6000 units/0.3 mL injection, 6 x 0.3 mL syringes (NeoRecormon)
6485H EPOETIN BETA, epoetin beta 10 000 units/0.6 mL injection, 6 x 0.6 mL syringes (NeoRecormon)
14213C OCTREOTIDE, octreotide 50 microgram/mL injection, 5 x 1 mL vials (Octreotide Acetate Omega (Canada))
14177E OCTREOTIDE, octreotide 100 microgram/mL injection, 5 x 1 mL vials (Octreotide Acetate Omega (Canada))
14201K OCTREOTIDE, octreotide 500 microgram/mL injection, 5 x 1 mL vials (Octreotide Acetate Omega (Canada))

Deletion – Brand

6100C AZACITIDINE EUGIA, YG – AZACITIDINE, azacitidine 100 mg injection, 1 vial
6138C AZACITIDINE EUGIA, YG – AZACITIDINE, azacitidine 100 mg injection, 1 vial
12784W AZACITIDINE EUGIA, YG – AZACITIDINE, azacitidine 100 mg injection, 1 vial
13033Y AZACITIDINE EUGIA, YG – AZACITIDINE, azacitidine 100 mg injection, 1 vial
13038F AZACITIDINE EUGIA, YG – AZACITIDINE, azacitidine 100 mg injection, 1 vial
13039G AZACITIDINE EUGIA, YG – AZACITIDINE, azacitidine 100 mg injection, 1 vial
13040H AZACITIDINE EUGIA, YG – AZACITIDINE, azacitidine 100 mg injection, 1 vial
6100C Azacitidine Sandoz, SZ – AZACITIDINE, azacitidine 100 mg injection, 1 vial
6138C Azacitidine Sandoz, SZ – AZACITIDINE, azacitidine 100 mg injection, 1 vial
12784W Azacitidine Sandoz, SZ – AZACITIDINE, azacitidine 100 mg injection, 1 vial
13033Y Azacitidine Sandoz, SZ – AZACITIDINE, azacitidine 100 mg injection, 1 vial
13038F Azacitidine Sandoz, SZ – AZACITIDINE, azacitidine 100 mg injection, 1 vial
13039G Azacitidine Sandoz, SZ – AZACITIDINE, azacitidine 100 mg injection, 1 vial
13040H Azacitidine Sandoz, SZ – AZACITIDINE, azacitidine 100 mg injection, 1 vial

Deletion – Note

6227R OCTREOTIDE, octreotide 50 microgram/mL injection, 5 x 1 mL ampoules (Octreotide GH, Octreotide (SUN), Sandostatin 0.05)
6228T OCTREOTIDE, octreotide 100 microgram/mL injection, 5 x 1 mL ampoules (Octreotide GH, Octreotide (SUN), Sandostatin 0.1)
6229W OCTREOTIDE, octreotide 500 microgram/mL injection, 5 x 1 mL ampoules (Octreotide GH, Octreotide (SUN), Sandostatin 0.5)

Alterations

Alteration – Note

11996J BENRALIZUMAB, benralizumab 30 mg/mL injection, 1 mL pen device (Fasenra Pen)
11997K BENRALIZUMAB, benralizumab 30 mg/mL injection, 1 mL pen device (Fasenra Pen)
11999M BENRALIZUMAB, benralizumab 30 mg/mL injection, 1 mL pen device (Fasenra Pen)
12313C DUPILUMAB, dupilumab 200 mg/1.14 mL injection, 2 x 1.14 mL syringes (Dupixent)
12316F DUPILUMAB, dupilumab 200 mg/1.14 mL injection, 2 x 1.14 mL syringes (Dupixent)
12294C DUPILUMAB, dupilumab 300 mg/2 mL injection, 2 x 2 mL syringes (Dupixent)
12310X DUPILUMAB, dupilumab 300 mg/2 mL injection, 2 x 2 mL syringes (Dupixent)
9613Y INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Ixifi, Remicade, Remsima, Renflexis)
11396T INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Ixifi, Remsima, Renflexis)
12043W MEPOLIZUMAB, mepolizumab 100 mg/mL injection, 1 mL pen device (Nucala)
12051G MEPOLIZUMAB, mepolizumab 100 mg/mL injection, 1 mL pen device (Nucala)
12052H MEPOLIZUMAB, mepolizumab 100 mg/mL injection, 1 mL pen device (Nucala)
10110D OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair)
11826K OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair)
11840E OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair)
14904K OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL pen device (Xolair)
14919F OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo)
14921H OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL pen device (Xolair)
14939G OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL pen device (Xolair)
10122R OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)
11825J OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)
11864K OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)
14883H OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL pen device (Xolair)
14923K OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL pen device (Xolair)
14927P OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)
14928Q OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL pen device (Xolair)
14912W OMALIZUMAB, omalizumab 300 mg/2 mL injection, 2 mL pen device (Xolair)
14951X OMALIZUMAB, omalizumab 300 mg/2 mL injection, 2 mL pen device (Xolair)
14953B OMALIZUMAB, omalizumab 300 mg/2 mL injection, 2 mL pen device (Xolair)
15234T RAVULIZUMAB, ravulizumab 300 mg/3 mL injection, 3 mL vial (Ultomiris)
15235W RAVULIZUMAB, ravulizumab 300 mg/3 mL injection, 3 mL vial (Ultomiris)
15263H RAVULIZUMAB, ravulizumab 300 mg/3 mL injection, 3 mL vial (Ultomiris)
15254W RAVULIZUMAB, ravulizumab 1.1 g/11 mL injection, 11 mL vial (Ultomiris)
15259D RAVULIZUMAB, ravulizumab 1.1 g/11 mL injection, 11 mL vial (Ultomiris)
15264J RAVULIZUMAB, ravulizumab 1.1 g/11 mL injection, 11 mL vial (Ultomiris)
11164N USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial (Stelara, Steqeyma, Wezlana)
10415E VEDOLIZUMAB, vedolizumab 300 mg injection, 1 vial (Entyvio)
14614E VEDOLIZUMAB, vedolizumab 300 mg injection, 1 vial (Entyvio)
15285L ZILUCOPLAN, Zilucoplan 16.6 mg/0.416 mL injection, 28 x 0.416 mL syringes (Zilbrysq)
15302J ZILUCOPLAN, Zilucoplan 16.6 mg/0.416 mL injection, 28 x 0.416 mL syringes (Zilbrysq)
15304L ZILUCOPLAN, Zilucoplan 23 mg/0.574 mL injection, 28 x 0.574 mL syringes (Zilbrysq)
15315C ZILUCOPLAN, Zilucoplan 23 mg/0.574 mL injection, 28 x 0.574 mL syringes (Zilbrysq)
15284K ZILUCOPLAN, Zilucoplan 32.4 mg/0.81 mL injection, 28 x 0.81 mL syringes (Zilbrysq)
15294Y ZILUCOPLAN, Zilucoplan 32.4 mg/0.81 mL injection, 28 x 0.81 mL syringes (Zilbrysq)

Alteration – Restriction

9648T AMBRISENTAN, ambrisentan 5 mg tablet, 30 (Ambrisentan Viatris, Cipla Ambrisentan, PULMORIS, Volibris)
12201E AMBRISENTAN, ambrisentan 5 mg tablet, 30 (Ambrisentan Viatris, Cipla Ambrisentan, PULMORIS, Volibris)
9649W AMBRISENTAN, ambrisentan 10 mg tablet, 30 (Ambrisentan Viatris, Cipla Ambrisentan, PULMORIS, Volibris)
12180C AMBRISENTAN, ambrisentan 10 mg tablet, 30 (Ambrisentan Viatris, Cipla Ambrisentan, PULMORIS, Volibris)
11997K BENRALIZUMAB, benralizumab 30 mg/mL injection, 1 mL pen device (Fasenra Pen)
6429J BOSENTAN, bosentan 62.5 mg tablet, 60 (Bosentan APO, BOSENTAN DR.REDDY'S, Bosentan RBX)
12139X BOSENTAN, bosentan 62.5 mg tablet, 60 (Bosentan APO, BOSENTAN DR.REDDY'S, Bosentan RBX)
12148J BOSENTAN, bosentan 62.5 mg tablet, 60 (Bosentan APO, BOSENTAN DR.REDDY'S, Bosentan RBX)
6430K BOSENTAN, bosentan 125 mg tablet, 60 (Bosentan APO, BOSENTAN DR.REDDY'S, Bosentan GH, Bosentan RBX, Bosentan Viatris)
12146G BOSENTAN, bosentan 125 mg tablet, 60 (Bosentan APO, BOSENTAN DR.REDDY'S, Bosentan GH, Bosentan RBX, Bosentan Viatris)
12313C DUPILUMAB, dupilumab 200 mg/1.14 mL injection, 2 x 1.14 mL syringes (Dupixent)
12310X DUPILUMAB, dupilumab 300 mg/2 mL injection, 2 x 2 mL syringes (Dupixent)
10111E EPOPROSTENOL, epoprostenol 500 microgram injection, 1 vial (Veletri)
10129D EPOPROSTENOL, epoprostenol 1.5 mg injection, 1 vial (Veletri)
6456T ILOPROST, iloprost 20 microgram/2 mL inhalation solution, 30 x 2 mL ampoules (Ventavis)
9613Y INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Ixifi, Remicade, Remsima, Renflexis)
11396T INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Ixifi, Remsima, Renflexis)
10134J MACITENTAN, macitentan 10 mg tablet, 30 (Opsumit)
12135Q MACITENTAN, macitentan 10 mg tablet, 30 (Opsumit)
12051G MEPOLIZUMAB, mepolizumab 100 mg/mL injection, 1 mL pen device (Nucala)
10110D OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair)
14904K OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL pen device (Xolair)
10122R OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)
14923K OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL pen device (Xolair)
14953B OMALIZUMAB, omalizumab 300 mg/2 mL injection, 2 mL pen device (Xolair)
9605M SILDENAFIL, sildenafil 20 mg tablet, 90 (SILDATIO PHT, Sildenafil PHT APOTEX, SILDENAFIL PHT ARX, Sildenafil Sandoz PHT 20)
12138W SILDENAFIL, sildenafil 20 mg tablet, 90 (SILDATIO PHT, Sildenafil PHT APOTEX, SILDENAFIL PHT ARX, Sildenafil Sandoz PHT 20)
1304P TADALAFIL, tadalafil 20 mg tablet, 56 (Adcirca, Tadalca, TADALIS 20)
12150L TADALAFIL, tadalafil 20 mg tablet, 56 (Adcirca, Tadalca, TADALIS 20)
14229X TADALAFIL, tadalafil 20 mg tablet, 60 (Tadalis 20)
14240L TADALAFIL, tadalafil 20 mg tablet, 60 (Tadalis 20)
11164N USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial (Stelara, Steqeyma, Wezlana)
10415E VEDOLIZUMAB, vedolizumab 300 mg injection, 1 vial (Entyvio)
14614E VEDOLIZUMAB, vedolizumab 300 mg injection, 1 vial (Entyvio)

Supply Only

Supply Only – Period Commencing

11399Y INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Ixifi, Remicade, Remsima, Renflexis)

Supply Only – Period Ending

14804E EDARAVONE, edaravone 30 mg/20 mL injection, 10 x 20 mL ampoules (Radicava)

Advance Notices

1 August 2026

Deletion – Item
14296K Onpattro, WM – PATISIRAN, patisiran 10 mg/5 mL injection, 5 mL vial
Deletion – Brand
9648T Cipla Ambrisentan, ZU – AMBRISENTAN, ambrisentan 5 mg tablet, 30
12201E Cipla Ambrisentan, ZU – AMBRISENTAN, ambrisentan 5 mg tablet, 30
6499C Pharmacor Deferasirox, CR – DEFERASIROX, deferasirox 125 mg dispersible tablet, 28
11236J Pharmacor Deferasirox, CR – DEFERASIROX, deferasirox 125 mg dispersible tablet, 28
11241P Pharmacor Deferasirox, CR – DEFERASIROX, deferasirox 125 mg dispersible tablet, 28
6500D Pharmacor Deferasirox, CR – DEFERASIROX, deferasirox 250 mg dispersible tablet, 28
11238L Pharmacor Deferasirox, CR – DEFERASIROX, deferasirox 250 mg dispersible tablet, 28
11244T Pharmacor Deferasirox, CR – DEFERASIROX, deferasirox 250 mg dispersible tablet, 28

Highly Specialised Drugs Program (Public Hospital)

Additions

Addition – Item

15391C ROZANOLIXIZUMAB, Rozanolixizumab 280 mg/2 mL injection, 2 mL vial (Rystiggo)
15398K ROZANOLIXIZUMAB, Rozanolixizumab 280 mg/2 mL injection, 2 mL vial (Rystiggo)
15403Q TEZEPELUMAB, Tezepelumab 210 mg/1.91 mL injection, 1.91 mL pen device (Tezspire)
15413F TEZEPELUMAB, Tezepelumab 210 mg/1.91 mL injection, 1.91 mL pen device (Tezspire)

Addition – Brand

11182M Wezlana, AN – USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial
13272M Wezlana, AN – USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial
13781H Wezlana, AN – USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial

Deletions

Deletion – Item

5724G EPOETIN BETA, epoetin beta 2000 units/0.3 mL injection, 6 x 0.3 mL syringes (NeoRecormon)
5725H EPOETIN BETA, epoetin beta 3000 units/0.3 mL injection, 6 x 0.3 mL syringes (NeoRecormon)
5726J EPOETIN BETA, epoetin beta 4000 units/0.3 mL injection, 6 x 0.3 mL syringes (NeoRecormon)
5727K EPOETIN BETA, epoetin beta 5000 units/0.3 mL injection, 6 x 0.3 mL syringes (NeoRecormon)
5728L EPOETIN BETA, epoetin beta 6000 units/0.3 mL injection, 6 x 0.3 mL syringes (NeoRecormon)
5729M EPOETIN BETA, epoetin beta 10 000 units/0.6 mL injection, 6 x 0.6 mL syringes (NeoRecormon)
14178F OCTREOTIDE, octreotide 50 microgram/mL injection, 5 x 1 mL vials (Octreotide Acetate Omega (Canada))
14219J OCTREOTIDE, octreotide 100 microgram/mL injection, 5 x 1 mL vials (Octreotide Acetate Omega (Canada))
14218H OCTREOTIDE, octreotide 500 microgram/mL injection, 5 x 1 mL vials (Octreotide Acetate Omega (Canada))

Deletion – Brand

9597D AZACITIDINE EUGIA, YG – AZACITIDINE, azacitidine 100 mg injection, 1 vial
9598E AZACITIDINE EUGIA, YG – AZACITIDINE, azacitidine 100 mg injection, 1 vial
12771E AZACITIDINE EUGIA, YG – AZACITIDINE, azacitidine 100 mg injection, 1 vial
13028Q AZACITIDINE EUGIA, YG – AZACITIDINE, azacitidine 100 mg injection, 1 vial
13036D AZACITIDINE EUGIA, YG – AZACITIDINE, azacitidine 100 mg injection, 1 vial
13042K AZACITIDINE EUGIA, YG – AZACITIDINE, azacitidine 100 mg injection, 1 vial
13044M AZACITIDINE EUGIA, YG – AZACITIDINE, azacitidine 100 mg injection, 1 vial
9597D Azacitidine Sandoz, SZ – AZACITIDINE, azacitidine 100 mg injection, 1 vial
9598E Azacitidine Sandoz, SZ – AZACITIDINE, azacitidine 100 mg injection, 1 vial
12771E Azacitidine Sandoz, SZ – AZACITIDINE, azacitidine 100 mg injection, 1 vial
13028Q Azacitidine Sandoz, SZ – AZACITIDINE, azacitidine 100 mg injection, 1 vial
13036D Azacitidine Sandoz, SZ – AZACITIDINE, azacitidine 100 mg injection, 1 vial
13042K Azacitidine Sandoz, SZ – AZACITIDINE, azacitidine 100 mg injection, 1 vial
13044M Azacitidine Sandoz, SZ – AZACITIDINE, azacitidine 100 mg injection, 1 vial

Deletion – Note

9508K OCTREOTIDE, octreotide 50 microgram/mL injection, 5 x 1 mL ampoules (Octreotide GH, Octreotide (SUN), Sandostatin 0.05)
9509L OCTREOTIDE, octreotide 100 microgram/mL injection, 5 x 1 mL ampoules (Octreotide GH, Octreotide (SUN), Sandostatin 0.1)
9510M OCTREOTIDE, octreotide 500 microgram/mL injection, 5 x 1 mL ampoules (Octreotide GH, Octreotide (SUN), Sandostatin 0.5)

Alterations

Alteration – Note

11994G BENRALIZUMAB, benralizumab 30 mg/mL injection, 1 mL pen device (Fasenra Pen)
11995H BENRALIZUMAB, benralizumab 30 mg/mL injection, 1 mL pen device (Fasenra Pen)
12000N BENRALIZUMAB, benralizumab 30 mg/mL injection, 1 mL pen device (Fasenra Pen)
12309W DUPILUMAB, dupilumab 200 mg/1.14 mL injection, 2 x 1.14 mL syringes (Dupixent)
12318H DUPILUMAB, dupilumab 200 mg/1.14 mL injection, 2 x 1.14 mL syringes (Dupixent)
12293B DUPILUMAB, dupilumab 300 mg/2 mL injection, 2 x 2 mL syringes (Dupixent)
12302L DUPILUMAB, dupilumab 300 mg/2 mL injection, 2 x 2 mL syringes (Dupixent)
5754W INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Ixifi, Remicade, Remsima, Renflexis)
11400B INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Ixifi, Remsima, Renflexis)
12007Y MEPOLIZUMAB, mepolizumab 100 mg/mL injection, 1 mL pen device (Nucala)
12021Q MEPOLIZUMAB, mepolizumab 100 mg/mL injection, 1 mL pen device (Nucala)
12064Y MEPOLIZUMAB, mepolizumab 100 mg/mL injection, 1 mL pen device (Nucala)
10118M OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair)
11835X OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair)
11846L OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair)
14905L OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL pen device (Xolair)
14947Q OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo)
14949T OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL pen device (Xolair)
14950W OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL pen device (Xolair)
10109C OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)
11824H OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)
11828M OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)
14884J OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL pen device (Xolair)
14922J OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL pen device (Xolair)
14929R OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL pen device (Xolair)
14948R OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)
14885K OMALIZUMAB, omalizumab 300 mg/2 mL injection, 2 mL pen device (Xolair)
14906M OMALIZUMAB, omalizumab 300 mg/2 mL injection, 2 mL pen device (Xolair)
14952Y OMALIZUMAB, omalizumab 300 mg/2 mL injection, 2 mL pen device (Xolair)
15244H RAVULIZUMAB, ravulizumab 300 mg/3 mL injection, 3 mL vial (Ultomiris)
15245J RAVULIZUMAB, ravulizumab 300 mg/3 mL injection, 3 mL vial (Ultomiris)
15255X RAVULIZUMAB, ravulizumab 300 mg/3 mL injection, 3 mL vial (Ultomiris)
15225H RAVULIZUMAB, ravulizumab 1.1 g/11 mL injection, 11 mL vial (Ultomiris)
15246K RAVULIZUMAB, ravulizumab 1.1 g/11 mL injection, 11 mL vial (Ultomiris)
15258C RAVULIZUMAB, ravulizumab 1.1 g/11 mL injection, 11 mL vial (Ultomiris)
11182M USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial (Stelara, Steqeyma, Wezlana)
10390W VEDOLIZUMAB, vedolizumab 300 mg injection, 1 vial (Entyvio)
14630B VEDOLIZUMAB, vedolizumab 300 mg injection, 1 vial (Entyvio)
15276B ZILUCOPLAN, Zilucoplan 16.6 mg/0.416 mL injection, 28 x 0.416 mL syringes (Zilbrysq)
15316D ZILUCOPLAN, Zilucoplan 16.6 mg/0.416 mL injection, 28 x 0.416 mL syringes (Zilbrysq)
15286M ZILUCOPLAN, Zilucoplan 23 mg/0.574 mL injection, 28 x 0.574 mL syringes (Zilbrysq)
15303K ZILUCOPLAN, Zilucoplan 23 mg/0.574 mL injection, 28 x 0.574 mL syringes (Zilbrysq)
15287N ZILUCOPLAN, Zilucoplan 32.4 mg/0.81 mL injection, 28 x 0.81 mL syringes (Zilbrysq)
15325N ZILUCOPLAN, Zilucoplan 32.4 mg/0.81 mL injection, 28 x 0.81 mL syringes (Zilbrysq)

Alteration – Restriction

5607D AMBRISENTAN, ambrisentan 5 mg tablet, 30 (Ambrisentan Viatris, Cipla Ambrisentan, PULMORIS, Volibris)
12212R AMBRISENTAN, ambrisentan 5 mg tablet, 30 (Ambrisentan Viatris, Cipla Ambrisentan, PULMORIS, Volibris)
5608E AMBRISENTAN, ambrisentan 10 mg tablet, 30 (Ambrisentan Viatris, Cipla Ambrisentan, PULMORIS, Volibris)
12186J AMBRISENTAN, ambrisentan 10 mg tablet, 30 (Ambrisentan Viatris, Cipla Ambrisentan, PULMORIS, Volibris)
11994G BENRALIZUMAB, benralizumab 30 mg/mL injection, 1 mL pen device (Fasenra Pen)
5618Q BOSENTAN, bosentan 62.5 mg tablet, 60 (Bosentan APO, BOSENTAN DR.REDDY'S, Bosentan RBX)
12134P BOSENTAN, bosentan 62.5 mg tablet, 60 (Bosentan APO, BOSENTAN DR.REDDY'S, Bosentan RBX)
12145F BOSENTAN, bosentan 62.5 mg tablet, 60 (Bosentan APO, BOSENTAN DR.REDDY'S, Bosentan RBX)
5619R BOSENTAN, bosentan 125 mg tablet, 60 (Bosentan APO, BOSENTAN DR.REDDY'S, Bosentan GH, Bosentan RBX, Bosentan Viatris)
12149K BOSENTAN, bosentan 125 mg tablet, 60 (Bosentan APO, BOSENTAN DR.REDDY'S, Bosentan GH, Bosentan RBX, Bosentan Viatris)
12309W DUPILUMAB, dupilumab 200 mg/1.14 mL injection, 2 x 1.14 mL syringes (Dupixent)
12293B DUPILUMAB, dupilumab 300 mg/2 mL injection, 2 x 2 mL syringes (Dupixent)
10130E EPOPROSTENOL, epoprostenol 500 microgram injection, 1 vial (Veletri)
10117L EPOPROSTENOL, epoprostenol 1.5 mg injection, 1 vial (Veletri)
5751Q ILOPROST, iloprost 20 microgram/2 mL inhalation solution, 30 x 2 mL ampoules (Ventavis)
5754W INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Ixifi, Remicade, Remsima, Renflexis)
11400B INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Ixifi, Remsima, Renflexis)
10136L MACITENTAN, macitentan 10 mg tablet, 30 (Opsumit)
12147H MACITENTAN, macitentan 10 mg tablet, 30 (Opsumit)
12007Y MEPOLIZUMAB, mepolizumab 100 mg/mL injection, 1 mL pen device (Nucala)
10118M OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair)
14949T OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL pen device (Xolair)
10109C OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo)
14884J OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL pen device (Xolair)
14885K OMALIZUMAB, omalizumab 300 mg/2 mL injection, 2 mL pen device (Xolair)
9547L SILDENAFIL, sildenafil 20 mg tablet, 90 (SILDATIO PHT, Sildenafil PHT APOTEX, SILDENAFIL PHT ARX, Sildenafil Sandoz PHT 20)
12144E SILDENAFIL, sildenafil 20 mg tablet, 90 (SILDATIO PHT, Sildenafil PHT APOTEX, SILDENAFIL PHT ARX, Sildenafil Sandoz PHT 20)
1308W TADALAFIL, tadalafil 20 mg tablet, 56 (Adcirca, Tadalca, TADALIS 20)
12151M TADALAFIL, tadalafil 20 mg tablet, 56 (Adcirca, Tadalca, TADALIS 20)
14271D TADALAFIL, tadalafil 20 mg tablet, 60 (Tadalis 20)
14281P TADALAFIL, tadalafil 20 mg tablet, 60 (Tadalis 20)
11182M USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial (Stelara, Steqeyma, Wezlana)
10390W VEDOLIZUMAB, vedolizumab 300 mg injection, 1 vial (Entyvio)
14630B VEDOLIZUMAB, vedolizumab 300 mg injection, 1 vial (Entyvio)

Supply Only

Supply Only – Period Commencing

11389K INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Ixifi, Remicade, Remsima, Renflexis)

Supply Only – Period Ending

14805F EDARAVONE, edaravone 30 mg/20 mL injection, 10 x 20 mL ampoules (Radicava)

Advance Notices

1 August 2026

Deletion – Item
14264R Onpattro, WM – PATISIRAN, patisiran 10 mg/5 mL injection, 5 mL vial
Deletion – Brand
5607D Cipla Ambrisentan, ZU – AMBRISENTAN, ambrisentan 5 mg tablet, 30
12212R Cipla Ambrisentan, ZU – AMBRISENTAN, ambrisentan 5 mg tablet, 30
5654N Pharmacor Deferasirox, CR – DEFERASIROX, deferasirox 125 mg dispersible tablet, 28
11235H Pharmacor Deferasirox, CR – DEFERASIROX, deferasirox 125 mg dispersible tablet, 28
11247Y Pharmacor Deferasirox, CR – DEFERASIROX, deferasirox 125 mg dispersible tablet, 28
5655P Pharmacor Deferasirox, CR – DEFERASIROX, deferasirox 250 mg dispersible tablet, 28
11239M Pharmacor Deferasirox, CR – DEFERASIROX, deferasirox 250 mg dispersible tablet, 28
11240N Pharmacor Deferasirox, CR – DEFERASIROX, deferasirox 250 mg dispersible tablet, 28

Highly Specialised Drugs Program (Community Access)

Supply Only

Supply Only – Period Ending

10349Q ATAZANAVIR, atazanavir 200 mg capsule, 60 (Reyataz)
10321F ATAZANAVIR, atazanavir 300 mg capsule, 30 (Reyataz)

Advance Notices

1 September 2026

Deletion – Brand
10311Q Lamivudine Alphapharm, AF – LAMIVUDINE, lamivudine 300 mg tablet, 30

Botulinum Toxin Program

Alterations

Alteration – Restriction

11016T BOTULINUM TOXIN TYPE A, botulinum toxin type A 100 units injection, 1 vial (Botox)

Growth Hormone Program

Additions

Addition – Item

15384Q SOMAPACITAN, somapacitan 10 mg/1.5 mL injection, 1.5 mL pen device (Sogroya)
15385R SOMAPACITAN, somapacitan 10 mg/1.5 mL injection, 1.5 mL pen device (Sogroya)
15367T SOMAPACITAN, somapacitan 15 mg/1.5 mL injection, 1.5 mL pen device (Sogroya)
15374E SOMAPACITAN, somapacitan 15 mg/1.5 mL injection, 1.5 mL pen device (Sogroya)
15394F SOMATROPIN, somatropin 15 mg/1.5 mL injection, 1.5 mL cartridge (SciTropin A)
15399L SOMATROPIN, somatropin 15 mg/1.5 mL injection, 1.5 mL cartridge (SciTropin A)
15417K SOMATROPIN, somatropin 15 mg/1.5 mL injection, 1.5 mL cartridge (SciTropin A)

Alterations

Alteration – Note

13119L SOMATROGON, somatrogon 24 mg/1.2 mL injection, 1.2 mL pen device (Ngenla)
13130C SOMATROGON, somatrogon 24 mg/1.2 mL injection, 1.2 mL pen device (Ngenla)
13120M SOMATROGON, somatrogon 60 mg/1.2 mL injection, 1.2 mL pen device (Ngenla)
13125T SOMATROGON, somatrogon 60 mg/1.2 mL injection, 1.2 mL pen device (Ngenla)

Alteration – Restriction

11493X SOMATROPIN, somatropin 5 mg injection [1 chamber] (&) inert substance diluent [1 mL chamber], 1 dual chamber pen device (Genotropin GoQuick)
11895C SOMATROPIN, somatropin 5 mg/1.5 mL injection, 1.5 mL cartridge (Norditropin FlexPro)
13712Q SOMATROPIN, somatropin 6 mg/1.03 mL injection, 1.03 mL cartridge (Saizen)
11495B SOMATROPIN, somatropin 12 mg injection [1 chamber] (&) inert substance diluent [1 mL chamber], 1 dual chamber pen device (Genotropin GoQuick)
13709M SOMATROPIN, somatropin 12 mg/1.5 mL injection, 1.5 mL cartridge (Saizen)

Repatriation Pharmaceutical Benefits

Additions

Addition – Item

15409B DRESSING HYDROFIBRE WITH SILVER, dressing hydrofibre with silver 2 cm x 45 cm ribbon, 5 (Aquacel Ag+ Ribbon 413571)
15373D DRESSING HYDROFIBRE WITH SILVER, dressing hydrofibre with silver 10 cm x 10 cm dressing, 10 (Aquacel Ag+ Extra 413567)
15396H DRESSING HYDROFIBRE WITH SILVER, dressing hydrofibre with silver 15 cm x 15 cm dressing, 5 (Aquacel Ag+ Extra 413568)
15372C MAGNESIUM, Magnesium 37.4 mg tablet, 120 (A-WON Magnesium)
15408Y PANTHENOL, panthenol conditioner, 250 g (SebiRinse)

Addition – Brand

4082W A-WON Calcium 600, WN – CALCIUM, calcium carbonate 1.5 g (calcium 600 mg) tablet, 120
4142B A-WON Calcium 600, WN – CALCIUM, calcium carbonate 1.5 g (calcium 600 mg) tablet, 120
14174B A-WON Calcium 600, WN – CALCIUM, calcium carbonate 1.5 g (calcium 600 mg) tablet, 120
14175C A-WON Calcium 600, WN – CALCIUM, calcium carbonate 1.5 g (calcium 600 mg) tablet, 120
4046Y Dofidaz, JM – DICLOFENAC, diclofenac sodium 3% gel, 25 g
10102Q Dutasteride/Tamsulosin Lupin 500/400, GQ – DUTASTERIDE + TAMSULOSIN, dutasteride 500 microgram + tamsulosin hydrochloride 400 microgram modified release capsule, 30
14184M Dutasteride/Tamsulosin Lupin 500/400, GQ – DUTASTERIDE + TAMSULOSIN, dutasteride 500 microgram + tamsulosin hydrochloride 400 microgram modified release capsule, 30
10102Q Dutasteride/Tamsulosin Sandoz 500/400, SZ – DUTASTERIDE + TAMSULOSIN, dutasteride 500 microgram + tamsulosin hydrochloride 400 microgram modified release capsule, 30
14184M Dutasteride/Tamsulosin Sandoz 500/400, SZ – DUTASTERIDE + TAMSULOSIN, dutasteride 500 microgram + tamsulosin hydrochloride 400 microgram modified release capsule, 30
4222F MAYNE PHARMA 5FU, SZ – FLUOROURACIL, fluorouracil 5% cream, 20 g
4591P GAPENTIN, RF – GABAPENTIN, gabapentin 100 mg capsule, 100
4592Q GAPENTIN, RF – GABAPENTIN, gabapentin 300 mg capsule, 100
4593R GAPENTIN, RF – GABAPENTIN, gabapentin 400 mg capsule, 100
4594T GAPENTIN, RF – GABAPENTIN, gabapentin 600 mg tablet, 100
10592L A-WON DIARRHOEA RELIEF CAPSULES, WN – LOPERAMIDE, loperamide hydrochloride 2 mg capsule, 12
11135C A-WON DIARRHOEA RELIEF CAPSULES, WN – LOPERAMIDE, loperamide hydrochloride 2 mg capsule, 20
10598T Chemists' Own Osteo Relief Paracetamol, RF – PARACETAMOL, paracetamol 665 mg modified release tablet, 96
4596X Tadalafil Sandoz Pharma, HX – TADALAFIL, tadalafil 10 mg tablet, 4
4597Y Tadalafil Sandoz Pharma, HX – TADALAFIL, tadalafil 20 mg tablet, 4
13307J Zopiclone GH, GQ – ZOPICLONE, zopiclone 7.5 mg tablet, 14

Addition – Equivalence Indicator

4046Y Solaraze 3% Gel, YN – DICLOFENAC, diclofenac sodium 3% gel, 25 g
10102Q Duodart 500ug/400ug, GK – DUTASTERIDE + TAMSULOSIN, dutasteride 500 microgram + tamsulosin hydrochloride 400 microgram modified release capsule, 30
14184M Duodart 500ug/400ug, GK – DUTASTERIDE + TAMSULOSIN, dutasteride 500 microgram + tamsulosin hydrochloride 400 microgram modified release capsule, 30
10592L Gastrex, CR – LOPERAMIDE, loperamide hydrochloride 2 mg capsule, 12

Deletions

Deletion – Item

10105W DRESSING HYDROFIBRE WITH SILVER, dressing hydrofibre with silver 2 cm x 45 cm ribbon, 5 (Aquacel Ag 403771)
10097K DRESSING HYDROFIBRE WITH SILVER, dressing hydrofibre with silver 10 cm x 10 cm dressing, 10 (Aquacel Ag 403708)
10098L DRESSING HYDROFIBRE WITH SILVER, dressing hydrofibre with silver 15 cm x 15 cm dressing, 5 (Aquacel Ag 403710)

Deletion – Brand

10598T Pharmacy Action OSTEO Relief 665, HQ – PARACETAMOL, paracetamol 665 mg modified release tablet, 96
4522B Imovane, SW – ZOPICLONE, zopiclone 7.5 mg tablet, 30
4522B Zopiclone GH, GQ – ZOPICLONE, zopiclone 7.5 mg tablet, 30

Efficient Funding of Chemotherapy (Private Hospital)

Additions

Addition – Item

15407X CYCLOPHOSPHAMIDE,
cyclophosphamide 1 g injection, 1 vial (Cyclophosphamide (NorthStar, USA));
cyclophosphamide 2 g injection, 1 vial (Cyclophosphamide (NorthStar, USA))
15369X PERTUZUMAB,
pertuzumab 420 mg/14 mL injection, 14 mL vial (Perjeta)
15411D PERTUZUMAB,
pertuzumab 420 mg/14 mL injection, 14 mL vial (Perjeta)
15379K ROMIDEPSIN,
romidepsin 10 mg injection [1 vial] (&) inert substance diluent [2 mL vial], 1 pack (ROMIDEPSIN-REACH)
15405T ROMIDEPSIN,
romidepsin 10 mg injection [1 vial] (&) inert substance diluent [2 mL vial], 1 pack (ROMIDEPSIN-REACH)

Addition – Brand

7249M Irinotecan Irem, KS – IRINOTECAN, irinotecan hydrochloride trihydrate 500 mg/25 mL injection, 25 mL vial
7255W PEMETREXED EUGIA, YG – PEMETREXED, pemetrexed 500 mg injection, 1 vial

Addition – Note

10308M PERTUZUMAB,
pertuzumab 420 mg/14 mL injection, 14 mL vial (Perjeta)
10334X PERTUZUMAB,
pertuzumab 420 mg/14 mL injection, 14 mL vial (Perjeta)
11271F PRALATREXATE,
pralatrexate 20 mg/mL injection, 1 mL vial (Folotyn)
11278N PRALATREXATE,
pralatrexate 20 mg/mL injection, 1 mL vial (Folotyn)

Alterations

Alteration – Restriction

11116C BLINATUMOMAB,
blinatumomab 38.5 microgram injection [1 vial] (&) inert substance solution [10 mL vial], 1 pack (Blincyto)
11271F PRALATREXATE,
pralatrexate 20 mg/mL injection, 1 mL vial (Folotyn)
11278N PRALATREXATE,
pralatrexate 20 mg/mL injection, 1 mL vial (Folotyn)

Advance Notices

1 August 2026

Deletion – Item
15145D Fludarabine Phosphate Injection, USP 50 mg/2 mL (Areva, USA), QY – FLUDARABINE, fludarabine phosphate 50 mg/2 mL injection, 2 mL vial

1 September 2026

Deletion – Brand
7253R Oxaliplatin SUN, RA – OXALIPLATIN, oxaliplatin 200 mg/40 mL injection, 40 mL vial

Efficient Funding of Chemotherapy (Public Hospital)

Additions

Addition – Item

15395G CYCLOPHOSPHAMIDE,
cyclophosphamide 1 g injection, 1 vial (Cyclophosphamide (NorthStar, USA));
cyclophosphamide 2 g injection, 1 vial (Cyclophosphamide (NorthStar, USA))
15386T PERTUZUMAB,
pertuzumab 420 mg/14 mL injection, 14 mL vial (Perjeta)
15402P PERTUZUMAB,
pertuzumab 420 mg/14 mL injection, 14 mL vial (Perjeta)
15370Y ROMIDEPSIN,
romidepsin 10 mg injection [1 vial] (&) inert substance diluent [2 mL vial], 1 pack (ROMIDEPSIN-REACH)
15387W ROMIDEPSIN,
romidepsin 10 mg injection [1 vial] (&) inert substance diluent [2 mL vial], 1 pack (ROMIDEPSIN-REACH)

Addition – Brand

4451G Irinotecan Irem, KS – IRINOTECAN, irinotecan hydrochloride trihydrate 500 mg/25 mL injection, 25 mL vial
4600D PEMETREXED EUGIA, YG – PEMETREXED, pemetrexed 500 mg injection, 1 vial

Addition – Note

10267J PERTUZUMAB,
pertuzumab 420 mg/14 mL injection, 14 mL vial (Perjeta)
10333W PERTUZUMAB,
pertuzumab 420 mg/14 mL injection, 14 mL vial (Perjeta)
11272G PRALATREXATE,
pralatrexate 20 mg/mL injection, 1 mL vial (Folotyn)
11293J PRALATREXATE,
pralatrexate 20 mg/mL injection, 1 mL vial (Folotyn)

Alterations

Alteration – Restriction

11118E BLINATUMOMAB,
blinatumomab 38.5 microgram injection [1 vial] (&) inert substance solution [10 mL vial], 1 pack (Blincyto)
11272G PRALATREXATE,
pralatrexate 20 mg/mL injection, 1 mL vial (Folotyn)
11293J PRALATREXATE,
pralatrexate 20 mg/mL injection, 1 mL vial (Folotyn)

Advance Notices

1 August 2026

Deletion – Item
15144C Fludarabine Phosphate Injection, USP 50 mg/2 mL (Areva, USA), QY – FLUDARABINE, fludarabine phosphate 50 mg/2 mL injection, 2 mL vial

1 September 2026

Deletion – Brand
4542C Oxaliplatin SUN, RA – OXALIPLATIN, oxaliplatin 200 mg/40 mL injection, 40 mL vial

Related Pharmaceutical Benefits for Public Hospital use

Advance Notices

1 August 2026

Deletion – Item
1899Y Leucovorin Calcium (Pfizer Australia Pty Ltd), PF – FOLINIC ACID, folinic acid 50 mg/5 mL injection, 10 x 5 mL ampoules
Last updated
1 July 2026